Pharmacogenomics of chemotherapy induced cognitive dysfunction
Cognitive decline is increasingly recognized as a side effect of chemotherapy. However, cognitive decline doesn't occur in all patients receiving chemotherapy, and there is variability in the cognitive domains affected (Ahles; JCO,Oct 20, 2012:3675-3686). Safety pharmacogenomics, i.e. using gen...
| Main Author: | |
|---|---|
| Other Authors: | |
| Format: | Others |
| Language: | English |
| Published: |
University of Iowa
2013
|
| Subjects: | |
| Online Access: | https://ir.uiowa.edu/etd/1528 https://ir.uiowa.edu/cgi/viewcontent.cgi?article=5580&context=etd |